OP
BPMC

ORG Partners’s Blueprint Medicines BPMC Stock Holding History

ORG Partners’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11
Closed -$1.41K – 1601
2025
Q2 		$1.41K Buy
11
+4
+57% +$415 ﹤0.01% 1290
2025
Q1 		$601 Buy
+7
New +$683 ﹤0.01% 1249

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ORG Partners's BPMC Position: Q3 2025 in Review

ORG Partners sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 11 shares — an estimated $1.41K sold.

ORG Partners first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $1.41K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • ORG Partners reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • ORG Partners sold 11 Blueprint Medicines shares in Q3 2025, an estimated $1.41K.
  • ORG Partners first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
  • ORG Partners's Blueprint Medicines position peaked at $1.41K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on ORG Partners's 13F filing for Q3 2025, filed 24 Oct 2025.